Table 2.
Frequencies of Charlson comorbidities in operative managed hip fracture patients by age cohort
| 75–89 years | ≥90 years | p value | |
|---|---|---|---|
| N = 144 | N = 54 | ||
| N (%) | N (%) | ||
| MI | 11 (7.64) | 2 (3.70) | ns |
| CHF | 12 (8.33) | 10 (18.52) | ns |
| CVD | 19 (13.19) | 9 (16.67) | ns |
| PVD | 23 (15.97) | 6 (11.11) | ns |
| Dementia | 27 (18.75) | 17 (31.48) | ns |
| Peptic ulcer | 2 (1.39) | 1 (1.85) | ns |
| Mild liver disease | 0 (0.00) | 1 (1.85) | ns |
| DM | 19 (13.19) | 5 (9.26) | ns |
| Connective tissue | 1 (0.69) | 0 (0.00) | ns |
| COPD | 15 (10.42) | 3 (5.56) | ns |
| Hemiplegia | 6 (4.17) | 0 (0.00) | ns |
| Mod–severe renal disease | 13 (9.03) | 4 (7.41) | ns |
| DM w/ end organ damage | 3 (2.08) | 0 (0.00) | ns |
| Tumor w/i 5 years | 25 (17.36) | 5 (9.26) | ns |
| Leukemia | 1 (0.69) | 1 (1.85) | ns |
| Lymphoma | 2 (1.39) | 0 (0.00) | ns |
| Mod–severe liver dz | 0 (0.00) | 0 (0.00) | |
| Metastatic solid tumor | 3 (2.08) | 0 (0.00) | ns |
| AIDS | 0 (0.00) | 0 (0.00) |